1. bookVolume 25 (2017): Issue 3 (July 2017)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients

Published Online: 01 Aug 2017
Page range: 255 - 263
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Objectives: Obesity is associated with oxidative stress due to the overproduction of free radicals in some accompanying states, such as hyperglycemia, elevated lipid levels and chronic inflammation. Free radical accumulation may modify the structure of human serum albumin, generating ischemia-modified albumin (IMA), and increased serum levels of IMA have been linked to obesity-related diseases and oxidative damage. The association of IMA levels with oxidative stress and insulin resistance (IR) has not been evaluated in the context of obesity. The aim of this study is to determine IMA levels in the context of obesity and their relationship with oxidative status and insulin resistance. Methods: Sixty-one adult obese cases with body mass index (BMI) ≥ 30 were evaluated, with 30 healthy adults with 18.5 ≤ BMI ≤ 24.9 included in the control group. IMA, total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), total cholesterol, triglycerides, HDL and LDL-cholesterols were determined. Results: IMA, TAS, TOS, OSI, total cholesterol and LDL-cholesterol levels were not different between the control and obese groups (P-value >0.05), while triglyceride levels were determined to be higher and HDL-cholesterol levels were determined to be lower in the obese group (P-value <0.05). When IMA, TAS, TOS, OSI levels were compared between the control/IR(-), obese/IR(+) and obese/IR(-) groups, no statistically significant differences were detected (P-value >0.05), but the fasting blood glucose level was determined to be higher in the obese/IR(+) group than in the control group. Conclusions: We concluded that obesity and insulin resistance had no effect on IMA levels in the obese group, who showed no impairment in their oxidative balance

Keywords

1. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031-41. DOI: 10.1152/ajpheart.01058.200410.1152/ajpheart.01058.200415653761Search in Google Scholar

2. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30(3):400-18. DOI: 10.1038/sj.ijo.0803177 10.1038/sj.ijo.080317716302012Search in Google Scholar

3. Powers SK, DeRuisseau KC, Quindry J, Hamilton KL. Dietary antioxidants and exercise. J Sports Sci. 2004;22(1):81-94. DOI: 10.1080/026404103100014056310.1080/026404103100014056314971435Search in Google Scholar

4. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol. 2003;23(3):365-7. DOI: 10.1161/01.ATV.0000063608.43095.E210.1161/01.ATV.0000063608.43095.E212639823Search in Google Scholar

5. Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord. 2001;25(3):378-88. DOI: 10.1038/sj.ijo.080153610.1038/sj.ijo.080153611319636Search in Google Scholar

6. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem. 2004;50(11):2190-3. DOI: 10.1373/clinchem.2004.03437110.1373/clinchem.2004.03437115502098Search in Google Scholar

7. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, et al. Association between ischemia- modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 2009;42(7-8):666-71. DOI: 10.1016/j.clinbiochem.2009.01.01010.1016/j.clinbiochem.2009.01.01019318029Search in Google Scholar

8. Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43(4- 5):450-4. DOI: 10.1016/j.clinbiochem.2009.11.01810.1016/j.clinbiochem.2009.11.01819968982Search in Google Scholar

9. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia- modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers. 2008;24(6):311-7. DOI: 10.1155/2008/78431310.1155/2008/784313385061518688079Search in Google Scholar

10. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab. 2010;95(2):586-91. DOI: 10.1210/jc.2009-159210.1210/jc.2009-1592284086820016051Search in Google Scholar

11. Bhagavan NV, Ha JS, Park JH, Honda SA, Rios CN, Sugiyama C, et al. Utility of serum Fatty Acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem. 2009;55(8):1588-90. DOI: 10.1373/clinchem.2008.12331510.1373/clinchem.2008.123315Search in Google Scholar

12. Aslan D, Apple FS. Ischemia modified albumin: clinical and analytical update, Lab Med. 2004;35(1):44-47. DOI: 10.1309/XXYETJN8YM9HBD9C 10.1309/XXYETJN8YM9HBD9CSearch in Google Scholar

13. Senes M, Kazan N, Coskun O, Zengi O, Inan L, Yucel D. Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem. 2007;44(Pt 1):43-7. DOI: 10.1258/00045630777959605710.1258/000456307779596057Search in Google Scholar

14. Yesilbursa D, Serdar Z, Serdar A, Sarac M, Coskun S, Jale C. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes (Lond). 2005;29(1):142-5. DOI: 10.1038/sj.ijo.080279410.1038/sj.ijo.0802794Search in Google Scholar

15. Prázný M, Skrha J, Hilgertová J. Plasma malondialdehyde and obesity: is there a relationship? Clin Chem Lab Med. 1999;37(11-12):1129-30. DOI: 10.1515/CCLM.1999.16410.1515/CCLM.1999.164Search in Google Scholar

16. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab. 2001;86(1):355-62.Search in Google Scholar

17. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627-31. DOI: 10.1016/S0009-9120(02)00363-610.1016/S0009-9120(02)00363-6Search in Google Scholar

18. World Health Organisation. Obesity: Preventing and managing the Global Epidemic. Report of a WHO Consultation on Obesity. ISBN 9241208945, 2000; 3-5.Search in Google Scholar

19. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112-9. DOI: 10.1016/j.clinbiochem. 2003.10.014Search in Google Scholar

20. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998;44(6 Pt 1):1309-15.10.1093/clinchem/44.6.1309Search in Google Scholar

21. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.00810.1016/j.clinbiochem.2005.08.008Search in Google Scholar

22. Verit FF, Verit A, Kocyigit A, Ciftci H, Celik H, Koksal M. No increase in sperm DNA damage and seminal oxidative stress in patients with idiopathic infertility. Arch Gynecol Obstet. 2006;274(6):339-44. DOI: 10.1007/s00404-006-0172-910.1007/s00404-006-0172-9Search in Google Scholar

23. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003;133(41-42):563-6.Search in Google Scholar

24. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt- albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19(4):311-5. DOI: 10.1016/S0736-4679(00)00255-910.1016/S0736-4679(00)00255-9Search in Google Scholar

25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. DOI: 10.1007/BF0028088310.1007/BF002808833899825Search in Google Scholar

26. Ozcelik O, Ozkan Y, Karatas F, Kelestimur H. Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects. Tohoku J Exp Med. 2005;206(4):313-8. DOI: 10.1620/tjem.206.31310.1620/tjem.206.31315997202Search in Google Scholar

27. Kurban S, Mehmetoglu I, Yerlikaya HF, Gonen S, Erdem S. Effect of chronic regular exercise on serum ischemia- modified albumin levels and oxidative stress in type 2 diabetes mellitus. Endocr Res. 2011;36(3):116-23. DOI: 10.3109/07435800.2011.56623610.3109/07435800.2011.56623621736494Search in Google Scholar

28. Brown LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity (Silver Spring). 2009;17(3):460-6. DOI: 10.1038/oby.2008.59010.1038/oby.2008.59019131942Search in Google Scholar

29. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP, Tonello R, et al. Ischemia modified albumin as an oxidative stress biomarker in obesity. Clin Biochem. 2011;44(4):345-7. DOI: 10.1016/j.clinbiochem.2010.12.00110.1016/j.clinbiochem.2010.12.00121159315Search in Google Scholar

30. Bourdon E, Loreau N, Lagrost L, Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic Res. 2005;39(1):15-20. DOI: 10.1080/1071576040002493510.1080/1071576040002493515875807Search in Google Scholar

31. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000;35(4):1009-15. DOI: 10.1161/01.HYP.35.4.100910.1161/01.HYP.35.4.100910775577Search in Google Scholar

32. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med. 2004;42(4):455-61. DOI: 10.1515/CCLM.2004.07910.1515/CCLM.2004.07915147158Search in Google Scholar

33. Piva SJ1, Tatsch E, De Carvalho JA, Bochi GV, Kober H, Duarte T, Duarte MM, da Cruz IB, Moretto MB, Moresco RN. Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index. Inflammation. 2013;36(1):226-31. DOI: 10.1007/s10753-012-9538-210.1007/s10753-012-9538-222961567Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo